Literature DB >> 4087196

Mechanism of nasal absorption of drugs. II: Absorption of L-tyrosine and the effect of structural modification on its absorption.

C H Huang, R Kimura, R Bawarshi-Nassar, A Hussain.   

Abstract

The nasal absorption of L-tyrosine and the effect of structural modification on that absorption have been studied using an in-situ experimental technique. The extent of nasal absorption of the amino acid was found to be the same at pH values of 4.0 and 7.4 but dependent on concentration in the range of 2.8 X 10(-4)-2.2 X 10(-3) M. O-Acyl-L-tyrosine esters, although possessing higher octanol-water (pH 7.4) partition coefficients, have the same rate of nasal absorption as the parent amino acid. N-Acetyl-L-tyrosine, on the other hand, was found to have both partition coefficient and nasal absorption rate similar to those of L-tyrosine. Esterification of the carboxyl moiety of L-tyrosine results in derivatives that hydrolyze in the in-situ perfusion medium generating the original amino acid. The rate of nasal absorption of these derivatives was, therefore, determined from an overall disappearance rate which accounted for the rate of hydrolysis to L-tyrosine. These carboxylic esters were absorbed 4 to 10 times faster than L-tyrosine. Although the carboxylic esters of L-tyrosine possess higher octanol-water partition coefficients than the parent amino acid, the differences in the rates of nasal absorption could not be attributed solely to partition coefficient. The enhancement in the rate of absorption observed for these esters was attributed instead to the absence of the negative charge on the carboxylate moiety. It is a result of this negative charge that the rates of nasal absorption of L-tyrosine, O-acyl-L-tyrosine esters and N-acetyl-L-tyrosine are similar, despite significant differences in their partition coefficients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4087196     DOI: 10.1002/jps.2600741210

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs.

Authors:  H D Kao; A Traboulsi; S Itoh; L Dittert; A Hussain
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  Intranasal delivery--modification of drug metabolism and brain disposition.

Authors:  Yin Cheong Wong; Zhong Zuo
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

3.  Drug absorption through mucosal membranes: effect of mucosal route and penetrant hydrophilicity.

Authors:  D C Corbo; J C Liu; Y W Chien
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

4.  The physicochemical properties, plasma enzymatic hydrolysis, and nasal absorption of acyclovir and its 2'-ester prodrugs.

Authors:  Z Shao; G B Park; R Krishnamoorthy; A K Mitra
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

5.  Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs.

Authors:  Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

6.  Targeted brain delivery of 17 beta-estradiol via nasally administered water soluble prodrugs.

Authors:  Abeer M Al-Ghananeem; Ashraf A Traboulsi; Lewis W Dittert; Anwar A Hussain
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

7.  In vitro polarized transport of L-phenylalanine in human nasal epithelium and partial characterization of the amino acid transporters involved.

Authors:  Remigius Agu; Hoang Vu Dang; Mark Jorissen; Tom Willems; Sandy Vandoninck; Johan Van Lint; Jackie V Vandenheede; Renaat Kinget; Norbert Verbeke
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

Review 8.  Chemoselective O-acylation of hydroxyamino acids and amino alcohols under acidic reaction conditions: History, scope and applications.

Authors:  Tor E Kristensen
Journal:  Beilstein J Org Chem       Date:  2015-04-08       Impact factor: 2.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.